XOMA Royalty Corp

XOMANasdaq· Pharmaceutical Preparations

Price History

Revenue

$6.7M

▲ 150.9% YoY

Net Income

-$13.8M

▲ 66.2% YoY

EPS

$-1.65

▲ 59.2% YoY

Cash

$101.7M

▼ 33.7% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.